Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February ...
Feb 11, 2015
0
92
Colon cancer is one of the most common types of cancer. Particularly in advanced stages of disease, the treatment still largely relies on traditional chemotherapy. The new generation of cancer treatments, so-called immunotherapies, ...
Mar 31, 2022
0
74
Cancer is a highly complex disease in which the tumor recruits its surrounding tissue, as well as the immune system to support and promote its own growth. This realization explains why tumor therapy has been difficult for ...
Nov 10, 2015
0
62
An international research team has identified "born to be bad" colorectal tumors in people with early stage cancer, which could help medical experts pinpoint and better treat aggressive tumors.
Dec 19, 2022
0
76
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...
Aug 27, 2015
0
226
Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum. These tumors are removed by surgery, ...
Nov 9, 2022
0
1032
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is ...
Apr 28, 2011
0
0
In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called 'mismatch repair' genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute ...
Jun 9, 2017
0
50
Researchers from the Massachusetts General Hospital (MGH) Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted ...
Feb 16, 2012
0
1
In one of the first successes of its kind, researchers from Case Western Reserve University School of Medicine and six other institutions have inhibited the spreading of cancer cells from one part of the body to another. ...
Feb 12, 2018
0
389
